Acadia Pharmaceuticals | ACAD - 员工总数

股票价格

21.74

每天变化

-0.83 -3.68%

每月一次

-1.05%

每年

49.11%

Q2 预测

21.15

金融业

USD

USD 1.56B

现金及等价物

USD 819.69M

USD 26.23M

USD 1.06B

USD 277.11M

USD 54.81M

USD 17.39M

USD 35.76M

653

EPS每股收益

USD 1.6

股本和储备

USD 917.27M

USD 257.76M

债务利息支出

USD 0

USD 8.25M

USD 0

USD 3.74B

USD 273.57M

USD 266.6M

USD 17.39M

普通股股本

USD 169.18M

11.61

USD 26.32M

USD 284M

销售和管理费用

USD 146.73M

USD 34.67M

贸易债权人

USD 10.9M

应收帐款人

USD 148.23M

	员工	更改		日
Acadia Pharmaceuticals	653		56	2024-12
ALKERMES	1.8K		300	2024-12
Alnylam Pharmaceuticals	2.23K		130	2024-12
Biogen	7.6K		35	2024-12
BioMarin Pharmaceutical	3.04K		361	2024-12
Bristol-Myers Squibb	34.1K		0	2024-12
Cara Therapeutics	55		51	2023-12
Corcept Therapeutics	500		148	2024-12
Cytokinetics	498		75	2024-12
Eisai	13.51K		2.44K	2025-12
Eli Lilly	47K		4K	2024-12
Incyte	2.62K		93	2024-12
J&J	138.1K		6.2K	2024-12
Moderna	5.8K		200	2024-12
Neurocrine Biosciences	1.8K		400	2024-12
Pfizer	81K		7K	2024-12
Prothena	163		10	2024-12
PTC Therapeutics	939		49	2024-12
Sarepta Therapeutics	1.37K		58	2024-12
Ultragenyx Pharmaceutical	1.29K		18	2024-12
Vanda Pharmaceuticals	203		87	2023-12
Vertex Pharmaceuticals	6.1K		700	2024-12